Significance of pretreatment cardiovascular morbidity as a risk factor during treatment with parenteral oestrogen or combined androgen deprivation of 915 patients with metastasized prostate cancer : evaluation of cardiovascular events in a randomized trial

Per Hedlund, Robert Johansson, Jan Damber, Inger Hagerman, Peter Henriksson, Peter Iversen, Peter Klarskov, Peter Mogensen, Finn Rasmussen, Eberhard Varenhorst, Teuvo Tammela

Research output: Contribution to journalArticleScientificpeer-review

15 Citations (Scopus)
Original languageEnglish
Pages (from-to)346-353
JournalScandinavian Journal of Urology and nephrology
Volume45
Issue number5
DOIs
Publication statusPublished - 2011
Publication typeA1 Journal article-refereed

Keywords

  • cardiovascular events
  • cardiovascular risk factors
  • combined androgen deprivation
  • parenteral oestrogen therapy
  • prostate cancer
  • randomized multicentre trial
  • skeletal metastases

Cite this